Revolutionizing Diabetes Management: Continuous Glucose Monitoring for Type 2 Diabetics
On World Diabetes Day, experts emphasize the need for continuous glucose monitoring (CGM) to be extended beyond Type 1 diabetics, potentially benefiting millions with Type 2. Currently, only one in four Type 2 patients on intensified insulin therapy use CGM systems, which offer real-time data to help manage blood sugar levels. The A continued focus on personalized treatment is highlighted, with artificial intelligence playing a crucial role in optimizing therapy, predicting hypoglycemia, and enhancing patient engagement. The need for wider access and insurance coverage for CGM devices remains a key challenge.